Xponance, Inc.

SEC CIK: 0001637541
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

RIGL holding history

Rigel Pharmaceuticals Inc in every 13F filed by Xponance, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RIGL overview All 13F holders of RIGL Full Q2 2026 holdings

Shares (Q2 2024): 0; Sold out in Q2 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2023

Holdings of RIGL by Xponance, Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2024	0	$0	0.0%	−1,012−100.0%	Sold outConverted for a 1-for-10 split	Holders
Q1 2024	10,121	$15.0K	<0.1%	00.0%	Unchanged	Holders
Q4 2023	10,121	$14.7K	<0.1%	+10,121	New	Holders